Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Chiasma Inc (CHMA)

Chiasma Inc (CHMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 217,681
  • Shares Outstanding, K 57,894
  • Annual Sales, $ 1,110 K
  • Annual Income, $ -74,780 K
  • 60-Month Beta 1.28
  • Price/Sales 209.38
  • Price/Cash Flow N/A
  • Price/Book 3.47
Trade CHMA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.61
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 08/09/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.32
  • Number of Estimates 3
  • High Estimate -0.31
  • Low Estimate -0.35
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +36.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.76 unch
on 08/05/21
4.72 -20.34%
on 07/06/21
-0.95 (-20.17%)
since 07/02/21
3-Month
3.70 +1.62%
on 05/06/21
4.93 -23.73%
on 06/25/21
-0.22 (-5.53%)
since 05/05/21
52-Week
2.77 +35.74%
on 03/29/21
5.74 -34.49%
on 09/14/20
-0.97 (-20.51%)
since 08/05/20

Most Recent Stories

More News
SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer

SpyBiotech, a British biotechnology company with a novel vaccine platform technology that can target infectious diseases, cancer, and chronic diseases, has appointed Mark Leuchtenberger as its Chief Executive...

CHMA : 3.76 (-6.00%)
NRSN : 1.5300 (-4.38%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates RAVN, BOCH, ONEM, CHMA; Shareholders are Encouraged to Contact the Firm

NEW YORK, July 24, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RAVN : 58.08 (+0.19%)
BOCH : 15.17 (-1.56%)
ONEM : 16.47 (+2.87%)
CHMA : 3.76 (-6.00%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates HGV, CHMA, ONDS, BOCH; Shareholders are Encouraged to Contact the Firm

NEW YORK, July 03, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

HGV : 43.70 (+0.39%)
CHMA : 3.76 (-6.00%)
ONDS : 0.9444 (-1.68%)
BOCH : 15.17 (-1.56%)
Chiasma Announces Submission of Marketing Authorization Application for MYCAPSSA® to the European Medicines Agency

Submission supported by previously announced data from Phase 3 MPOWEREDâ„¢ study

CHMA : 3.76 (-6.00%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ARPO, ONDS, CHMA, and PFOH Shareholders About Its Ongoing Investigations

NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) --

ARPO : 33.00 (-0.90%)
ONDS : 0.9444 (-1.68%)
CHMA : 3.76 (-6.00%)
PFOH : 40.2000 (+0.50%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ONDS, CHMA, PFOH, and HGV Shareholders About Its Ongoing Investigations

NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) --

ONDS : 0.9444 (-1.68%)
CHMA : 3.76 (-6.00%)
PFOH : 40.2000 (+0.50%)
HGV : 43.70 (+0.39%)
Amryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of Chiasma, Inc.

Amryt Pharma Announces Filing of Preliminary Registration Statement on Form F-4 in Connection with Its Proposed Acquisition of Chiasma, Inc.

LSE.LN : 8,620.000 (-0.58%)
AMYT : 14.70 (+0.07%)
CHMA : 3.76 (-6.00%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates PFPT, MDP, CHMA, EQT; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 11, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

PFPT : 175.90 (-0.02%)
MDP : 59.07 (+0.12%)
CHMA : 3.76 (-6.00%)
EQT : 36.52 (-1.96%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CHMA, PFOH, PTON, and HGV Shareholders About Its Ongoing Investigations

NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) --

CHMA : 3.76 (-6.00%)
PFOH : 40.2000 (+0.50%)
PTON : 3.29 (-7.32%)
HGV : 43.70 (+0.39%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CHMA, PFOH, PTON, and HGV Shareholders About Its Ongoing Investigations

NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) --

CHMA : 3.76 (-6.00%)
PFOH : 40.2000 (+0.50%)
PTON : 3.29 (-7.32%)
HGV : 43.70 (+0.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Chiasma, Inc. is a biopharmaceutical company. The company's TPE(R) technology develops oral peptides and other molecules. Its primary product candidate consists of oral octreotide which is in different clinical trial. Chiasma, Inc. is based in Newton, USA.

See More

Key Turning Points

3rd Resistance Point 4.33
2nd Resistance Point 4.21
1st Resistance Point 3.99
Last Price 3.76
1st Support Level 3.65
2nd Support Level 3.53
3rd Support Level 3.31

See More

52-Week High 5.74
Fibonacci 61.8% 4.61
Fibonacci 50% 4.26
Fibonacci 38.2% 3.90
Last Price 3.76
52-Week Low 2.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar